login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
MEREO BIOPHARMA GROUP PL-ADR (MREO) Stock News
NASDAQ:MREO -
US5894921072
-
ADR
1.7
USD
+0.05 (+3.03%)
Last: 8/22/2025, 8:25:11 PM
1.7
USD
0 (0%)
After Hours:
8/22/2025, 8:25:11 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MREO Latest News, Press Relases and Analysis
All
Press Releases
3 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
7 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
11 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
2 months ago - By: Benzinga
- Mentions:
DALN
RARE
CURR
BTCM
...
US Stocks Mixed; Initial Jobless Claims Fall
13 days ago - By: Mereo BioPharma Group plc
Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights
13 days ago - By: Mereo BioPharma Group plc
Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights
13 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
14 days ago - By: Yahoo Finance
- Mentions:
RARE
Mereo BioPharma Group (MREO) Announced Progress in the Phase 3 Orbit Study Testing UX143
15 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
19 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
23 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
24 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
a month ago - By: Benzinga
- Mentions:
RARE
Ultragenyx Represents 'Intriguing Buying Opportunity,' Despite Recent Setbacks
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
2 months ago - By: Investor's Business Daily
- Mentions:
RY
RY.CA
RARE
Ultragenyx, Mereo Hammered For Their Surprise Miss In Brittle Bone Disease
2 months ago - By: Ultragenyx Pharmaceutical Inc.
- Mentions:
RARE
Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis
3 months ago - By: Mereo BioPharma Group plc
Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights
3 months ago - By: Mereo BioPharma Group plc
Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights
4 months ago - By: Yahoo Finance
Mereo BioPharma Group plc (MREO): A Bull Case Theory
4 months ago - By: Yahoo Finance
- Mentions:
PLTR
AAPL
USB
Is Mereo BioPharma Group (NASDAQ:MREO) the Best Biotech Penny Stock to Buy According to Hedge Funds?
Please enable JavaScript to continue using this application.